文献速递慢阻肺

中国人群支气管舒张前后肺功能参考值的应用影响

Impact of Using Pre- and Postbronchodilator Spirometry Reference Values in a Chinese Population.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

基于中国肺健康研究(CPH)17,969名健康不吸烟者建立支气管舒张前后FEV1、FVC及FEV1/FVC参考值,并应用于全部50,991名参与者。使用舒张后参考值时气流受限患病率为8.02%,高于舒张前参考值的5.36%;舒张后参考值可额外识别3.51%的II-IV级慢阻肺患者。

要点

  • 中国成人肺功能参考值应区分支气管舒张前后。
  • 使用舒张后参考值气流受限患病率为8.02%,高于舒张前5.36%。
  • 舒张后参考值可额外识别3.51%的II-IV级慢阻肺患者。

核心结论

  • 基于全国代表性中国成人队列建立了支气管舒张前后肺功能参考值。
  • 舒张后参考值可作为识别阻塞性肺疾病风险人群的附加标准。

研究设计与样本

  • 基于中国肺健康研究(CPH),参考人群为17,969名健康不吸烟参与者。
  • 参考值应用于全部CPH人群(N=50,991)以比较疾病患病率和严重度分级差异。

主要发现

  • 使用舒张前参考值时气流受限患病率为5.36%,使用舒张后参考值为8.02%。
  • 舒张后FEV1/FVC低于舒张后参考值但高于舒张前参考值者,自报呼吸道症状率显著更高且肺功能指标显著更低。
  • 使用舒张后FEV1预计值额外识别3.51%的参与者为II-IV级慢阻肺。

关键数值与推荐

  • 参考值计算对象为CPH研究中17,969名健康不吸烟参与者,指标包括FEV1、FVC和FEV1/FVC。
  • 气流受限患病率:舒张前参考值5.36%,舒张后参考值8.02%。
  • 额外识别II-IV级慢阻肺比例:3.51%(基于舒张后FEV1预计值)。

临床怎么用

  • 中国成人肺功能评估应考虑使用支气管舒张后参考值。
  • 舒张后参考值有助于识别舒张前参考值漏诊的阻塞性肺疾病风险个体。

局限性

  • 舒张后参考值的诊断和预后价值尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Spirometry reference equations that are derived from a large, nationally representative general population are warranted in China, and the impact of using prebronchodilator (pre-BD) and post-BD spirometry reference values has yet to be assessed in Chinese populations. Objectives: To present the pre-BD and post-BD spirometry reference values for Chinese adults using the China Pulmonary Health (CPH) Study. Methods: A reference population of 17,969 healthy, nonsmoking participants in the CPH Study was used to calculate the pre- and post-BD reference values for FEV1, FVC, and FEV1/FVC ratio. Pre- and post-BD reference values were applied to the entire CPH population (N = 50,991) to illustrate the divergence between the use of different references in determining disease prevalence and severity grading. Measurements and Main Results: The prevalences of airflow limitation were 5.36% using the pre-BD reference and 8.02% using the post-BD reference. Individuals who had a post-BD FEV1/FVC ratio lower than the post-BD reference value but higher than the pre-BD reference value were found to have significantly higher rates of self-reported respiratory symptoms and significantly lower values on spirometry indicators than those whose post-BD FEV1/FVC ratio was greater than the post-BD reference value. An additional 3.51% of participants were identified as having grade II-IV chronic obstructive pulmonary disease using the post-BD FEV1 predicted values. Conclusions: This study generated and applied pre- and post-BD spirometry reference values in a nationally representative Chinese adult population. Post-BD reference values may serve as an additional criterion in identifying individuals at risk for obstructive pulmonary diseases, and their diagnostic and prognostic values should be further investigated.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Huang K, Han X, Pan Z, et al. Impact of Using Pre- and Postbronchodilator Spirometry Reference Values in a Chinese Population. Am J Respir Crit Care Med. 2024. PMID: 38687500. doi:10.1164/rccm.202308-1488OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。